Craig Winstanley focuses on Pseudomonas aeruginosa, Microbiology, Cystic fibrosis, Immunology and Virulence. The various areas that Craig Winstanley examines in his Pseudomonas aeruginosa study include Genotyping, Genotype, Respiratory infection, Antibiotic resistance and Genetic variation. His Microbiology study combines topics from a wide range of disciplines, such as Genetics, Gene, Genetic diversity, Biofilm and Tobramycin.
His research integrates issues of Chronic infection, Pyocyanin and Outpatient clinic in his study of Cystic fibrosis. His work on Spirometry is typically connected to Respiratory equipment as part of general Immunology study, connecting several disciplines of science. His research investigates the connection with Virulence and areas like Pathogen which intersect with concerns in Regulon, Frameshift mutation, Pilin and Keratitis.
The scientist’s investigation covers issues in Microbiology, Pseudomonas aeruginosa, Cystic fibrosis, Genetics and Gene. His Microbiology study integrates concerns from other disciplines, such as Biofilm, Bacteria, Genotype and Virulence. His research investigates the connection between Pseudomonas aeruginosa and topics such as Antibiotics that intersect with problems in Tobramycin.
His biological study spans a wide range of topics, including Phenotype, Pyocyanin, Lung and Pathology. His work in Genome, Flagellin, Multilocus sequence typing, Plasmid and Restriction fragment length polymorphism are all subfields of Genetics research. His work deals with themes such as Marker gene and Recombinant DNA, which intersect with Plasmid.
Craig Winstanley mainly focuses on Pseudomonas aeruginosa, Microbiology, Cystic fibrosis, Genetics and Antibiotic resistance. The Pseudomonas aeruginosa study combines topics in areas such as Antibiotics and Antimicrobial. His Microbiology research includes themes of Biofilm and Type three secretion system, Virulence.
His Cystic fibrosis research is multidisciplinary, relying on both Gene expression and Lung infection. His Lung infection research integrates issues from National registry, Ivacaftor and Immunology. In his study, Genetic structure, Chronic infection, Lineage, Genetic diversity and Genotyping is strongly linked to Strain, which falls under the umbrella field of Antibiotic resistance.
His primary areas of investigation include Pseudomonas aeruginosa, Genetics, Antibiotic resistance, Antibiotics and Microbiology. His Pseudomonas aeruginosa research incorporates elements of Internal medicine and Cystic fibrosis. His study in Cystic fibrosis is interdisciplinary in nature, drawing from both National registry, Downregulation and upregulation, Cohort study and Lung infection.
The concepts of his Antibiotic resistance study are interwoven with issues in Mutation, Exotoxin, Tobramycin and Keratitis. His Antibiotics research incorporates themes from Phage therapy, Eye infection and Virulence. Microbiology is closely attributed to Biofilm in his work.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pseudomonas genomes: diverse and adaptable
Mark W. Silby;Mark W. Silby;Craig Winstanley;Scott A.C. Godfrey;Stuart B. Levy.
Fems Microbiology Reviews (2011)
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
Craig Winstanley;Siobhan O’Brien;Michael A. Brockhurst.
Trends in Microbiology (2016)
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
K. Cheng;R. L. Smyth;J. R. W. Govan;C. Doherty.
The Lancet (1996)
Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa.
Craig Winstanley;Morgan G.I. Langille;Joanne L. Fothergill;Irena Kukavica-Ibrulj.
Genome Research (2009)
Pseudomonas aeruginosa Population Diversity and Turnover in Cystic Fibrosis Chronic Infections
Eilidh Mowat;Steve Paterson;Joanne L. Fothergill;Joanne L. Fothergill;Elli A. Wright.
American Journal of Respiratory and Critical Care Medicine (2011)
A Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa Displays Enhanced Virulence and Antimicrobial Resistance
Prabhakar Salunkhe;Catherine H. M. Smart;J. Alun W. Morgan;Stavroula Panagea.
Journal of Bacteriology (2005)
Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer
Maelle Prorok-Hamon;Melissa K Friswell;Abdullah Alswied;Carol L Roberts.
The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.
Craig Winstanley;Craig Winstanley;Joanne L. Fothergill;Joanne L. Fothergill.
Fems Microbiology Letters (2009)
Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients
M Al-Aloul;J Crawley;C Winstanley;C A Hart.
Distribution of type III secretion gene clusters in Burkholderia pseudomallei, B. thailandensis and B. mallei.
Lucille Rainbow;C. Anthony Hart;Craig Winstanley.
Journal of Medical Microbiology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: